Ameriprise
APTX

Ameriprise’s Aptinyx Inc. Common Stock APTX Stock Holding History

Ameriprise’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,200
Closed -$7K – 4055
2022
Q2 		$7K Sell
13,200
-1,000
-7% -$803 ﹤0.01% 3871
2022
Q1 		$32K Sell
14,200
-3,000
-17% -$8.99K ﹤0.01% 3891
2021
Q4 		$46K Hold
17,200
– – ﹤0.01% 3906
2021
Q3 		$40K Sell
17,200
-2,000
-10% -$5.1K ﹤0.01% 3822
2021
Q2 		$54K Buy
19,200
+3,900
+25% +$10.9K ﹤0.01% 3852
2021
Q1 		$46K Buy
+15,300
New +$55K ﹤0.01% 3804
2020
Q4 		– Sell
-13,671
Closed -$46K – 3845
2020
Q3 		$46K Buy
13,671
+2,000
+17% +$7.67K ﹤0.01% 3679
2020
Q2 		$49K Buy
+11,671
New +$39.5K ﹤0.01% 3620
2020
Q1 		– Sell
-19,386
Closed -$66K – 3761
2019
Q4 		$66K Sell
19,386
-5
-0% -$17 ﹤0.01% 3658
2019
Q3 		$68K Buy
+19,391
New +$69.7K ﹤0.01% 3653

Other funds holding APTX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ameriprise's APTX Position: Q3 2022 in Review

Ameriprise sold out of Aptinyx Inc. Common Stock (APTX) in Q3 2022, closing a stake of 13,200 shares — an estimated $7K sold.

Ameriprise first reported a position in APTX in Q3 2019 and held it in 10 quarters. The position peaked at $68K in Q3 2019. 40 funds tracked by Wall St. Rank hold APTX as of Q3 2022.

  • Ameriprise reported no remaining Aptinyx Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 13,200 Aptinyx Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Ameriprise first reported a position in Aptinyx Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • Ameriprise's Aptinyx Inc. Common Stock position peaked at $68K in Q3 2019.
  • 40 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.